Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing
Ist Teil von
Nature genetics, 2016-09, Vol.48 (9), p.1060-1065
Ort / Verlag
New York: Nature Publishing Group US
Erscheinungsjahr
2016
Quelle
MEDLINE
Beschreibungen/Notizen
Matthew Hurles and colleagues report exome sequencing of 1,891 individuals with syndromic or nonsyndromic congenital heart defects (CHD). They found that nonsyndromic CHD patients were enriched for protein-truncating variants in CHD-associated genes inherited from unaffected parents and identified three new syndromic CHD disorders caused by
de novo
mutations.
Congenital heart defects (CHDs) have a neonatal incidence of 0.8–1% (refs.
1
,
2
). Despite abundant examples of monogenic CHD in humans and mice, CHD has a low absolute sibling recurrence risk (∼2.7%)
3
, suggesting a considerable role for
de novo
mutations (DNMs) and/or incomplete penetrance
4
,
5
.
De novo
protein-truncating variants (PTVs) have been shown to be enriched among the 10% of 'syndromic' patients with extra-cardiac manifestations
6
,
7
. We exome sequenced 1,891 probands, including both syndromic CHD (S-CHD,
n
= 610) and nonsyndromic CHD (NS-CHD,
n
= 1,281). In S-CHD, we confirmed a significant enrichment of
de novo
PTVs but not inherited PTVs in known CHD-associated genes, consistent with recent findings
8
. Conversely, in NS-CHD we observed significant enrichment of PTVs inherited from unaffected parents in CHD-associated genes. We identified three genome-wide significant S-CHD disorders caused by DNMs in
CHD4
,
CDK13
and
PRKD1
. Our study finds evidence for distinct genetic architectures underlying the low sibling recurrence risk in S-CHD and NS-CHD.